|
RAB9A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.793300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.687610E-02 |
| Normal-vs-Stage2 |
1.539850E-02 |
| Normal-vs-Stage3 |
1.029960E-04 |
| Normal-vs-Stage4 |
9.397500E-04 |
| Stage1-vs-Stage2 |
4.220600E-01 |
| Stage1-vs-Stage3 |
5.435800E-03 |
| Stage1-vs-Stage4 |
3.522500E-02 |
| Stage2-vs-Stage3 |
2.385200E-01 |
| Stage2-vs-Stage4 |
3.864400E-01 |
| Stage3-vs-Stage4 |
7.933400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.985700E-04 |
| Normal-vs-AfricanAmerican |
2.604100E-02 |
| Normal-vs-Asian |
9.055600E-01 |
| Caucasian-vs-AfricanAmerican |
9.281400E-01 |
| Caucasian-vs-Asian |
6.300600E-01 |
| AfricanAmerican-vs-Asian |
4.767400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.75149999999925E-05 |
| Normal-vs-Female |
2.740300E-02 |
| Male-vs-Female |
5.010300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.861880E-02 |
| Normal-vs-Age(41-60Yrs) |
2.161700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.816800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.318600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.131400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.872000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.374400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.894600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.212000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.023000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.803800E-02 |
| Normal-vs-Grade 2 |
2.114000E-02 |
| Normal-vs-Grade 3 |
9.440300E-04 |
| Normal-vs-Grade 4 |
2.31799999999005E-05 |
| Grade 1-vs-Grade 2 |
7.887600E-01 |
| Grade 1-vs-Grade 3 |
7.805000E-01 |
| Grade 1-vs-Grade 4 |
2.127000E-01 |
| Grade 2-vs-Grade 3 |
2.081000E-01 |
| Grade 2-vs-Grade 4 |
4.184000E-03 |
| Grade 3-vs-Grade 4 |
3.699800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.746020E-02 |
| Normal-vs-ccB subtype |
1.430410E-02 |
| ccA subtype-vs-ccB subtype |
3.771800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.260100E-03 |
| Normal-vs-N1 |
3.181200E-03 |
| N0-vs-N1 |
1.269990E-01 |
|
|
